RSA-measured in Vivo Migration and Micromotion in the DePuy Tri-Lock, Corail and Deltamotion Hip Replacement Components
Launched by UNIVERSITY OF OXFORD · Feb 25, 2016
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Women aged between 18 and 65 years and men aged between 18 and 70 years.
- • Participant is willing and able to give informed consent for participation in the study.
- • Diagnosed with hip osteoarthritis.
- • Able (in the Investigators opinion) and willing to comply with all study requirements.
- • Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study.
- Exclusion Criteria:
- • Any patients with an inflammatory arthropathy, osteoporosis or deformities of the proximal femur.
- • Patients who have significant co-morbidities that would make follow-up difficult or uncomfortable.
- • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials